Twitter LinkedIn YouTube iTune Podcast Google Podcasts Spotify

Predictmedix Inc.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Predictmedix Inc.

Punching above their weight, Predictmedix keeps nailing the heavyweight health tech partnerships

As the world shifts to a “new” normal, employee and customer screenings will be commonplace and Predictmedix Inc. (CSE: PMED […]

Dr. Rahul Kushwah on Predictmedix’s remote patient monitoring technology and Mobile Wellbeing

In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Rahul Kushwah, Co-Founder and COO of Predictmedix Inc. (CSE: PMED […]

Predictmedix is starting to commercialize as AI health screening & monitoring takes off

Health screening is big business these days. The latest way is using Artificial Intelligence (AI) to mass screen and/or monitor […]

Company Overview

Website

Predictmedix Inc. is an artificial intelligence (“AI”) company developing disruptive tools for impairment testing and healthcare. It is intended that the Company’s cannabis and alcohol impairment detection tools will be used across various workplaces and by law enforcement agents. Its technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. Testing does not require any body fluids or human intervention, thereby helping to remove human error and the potential for discrimination and prejudice. Predictmedix Inc. is expanding its proprietary AI technology to screen for infectious diseases for identification of symptomatic individuals.

News Releases

View All News

Twitter LinkedIn YouTube Amazon Alexa iTune Podcast Google Podcasts Spotify